These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. Hamada S; Matsumoto R; Tanaka Y; Taguchi K; Yamamoto M; Masamune A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672789 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice. Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025 [TBL] [Abstract][Full Text] [Related]
5. Kidney epithelium specific deletion of kelch-like ECH-associated protein 1 (Keap1) causes hydronephrosis in mice. Noel S; Arend LJ; Bandapalle S; Reddy SP; Rabb H BMC Nephrol; 2016 Aug; 17(1):110. PubMed ID: 27484495 [TBL] [Abstract][Full Text] [Related]
6. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp. Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis. Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543 [TBL] [Abstract][Full Text] [Related]
8. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis. Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152 [TBL] [Abstract][Full Text] [Related]
9. Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors. Hayashi M; Kuga A; Suzuki M; Panda H; Kitamura H; Motohashi H; Yamamoto M Cancer Res; 2020 Aug; 80(16):3331-3344. PubMed ID: 32636316 [TBL] [Abstract][Full Text] [Related]
10. Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice. Yagishita Y; Fukutomi T; Sugawara A; Kawamura H; Takahashi T; Pi J; Uruno A; Yamamoto M Diabetes; 2014 Feb; 63(2):605-18. PubMed ID: 24186865 [TBL] [Abstract][Full Text] [Related]
11. Keap1-Nrf2 signalling in pancreatic cancer. Hayes AJ; Skouras C; Haugk B; Charnley RM Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456 [TBL] [Abstract][Full Text] [Related]
12. Mice Hypomorphic for Ziros PG; Renaud CO; Chartoumpekis DV; Bongiovanni M; Habeos IG; Liao XH; Refetoff S; Kopp PA; Brix K; Sykiotis GP Thyroid; 2021 Jan; 31(1):23-35. PubMed ID: 32689903 [No Abstract] [Full Text] [Related]
13. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405. Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506 [TBL] [Abstract][Full Text] [Related]
14. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus. Suzuki T; Seki S; Hiramoto K; Naganuma E; Kobayashi EH; Yamaoka A; Baird L; Takahashi N; Sato H; Yamamoto M Nat Commun; 2017 Feb; 8():14577. PubMed ID: 28233855 [TBL] [Abstract][Full Text] [Related]
15. KEAP1/NRF2 axis regulates H He J; Zhang X; Lian C; Wu J; Fang Y; Ye X Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636 [TBL] [Abstract][Full Text] [Related]
16. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Jeong Y; Hoang NT; Lovejoy A; Stehr H; Newman AM; Gentles AJ; Kong W; Truong D; Martin S; Chaudhuri A; Heiser D; Zhou L; Say C; Carter JN; Hiniker SM; Loo BW; West RB; Beachy P; Alizadeh AA; Diehn M Cancer Discov; 2017 Jan; 7(1):86-101. PubMed ID: 27663899 [TBL] [Abstract][Full Text] [Related]
17. Nrf2-Keap1 defines a physiologically important stress response mechanism. Motohashi H; Yamamoto M Trends Mol Med; 2004 Nov; 10(11):549-57. PubMed ID: 15519281 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257 [TBL] [Abstract][Full Text] [Related]
19. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157 [TBL] [Abstract][Full Text] [Related]
20. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. Namani A; Matiur Rahaman M; Chen M; Tang X BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]